![Charles Reay Mackay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Reay Mackay
Gründer bei G2 Therapies Pty Ltd.
Aktive Positionen von Charles Reay Mackay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
G2 Therapies Pty Ltd.
![]() G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | Direktor/Vorstandsmitglied | 29.10.2010 | - |
Gründer | 29.10.2010 | - |
Karriereverlauf von Charles Reay Mackay
Ehemalige bekannte Positionen von Charles Reay Mackay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The Garvan Institute of Medical Research
![]() The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Corporate Officer/Principal | - | - |
Statistik
International
Australien | 3 |
Operativ
Director/Board Member | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
G2 Therapies Pty Ltd.
![]() G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | Health Technology |
The Garvan Institute of Medical Research
![]() The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Commercial Services |
- Börse
- Insiders
- Charles Reay Mackay
- Erfahrung